Asarfi Hospital Limited (BOM:543943)
India · Delayed Price · Currency is INR 199.50
+1.60 (0.81%)
At close: Dec 5, 2025
Asarfi Hospital Income Statement
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | 2020 |
| 1,474 | 1,206 | 844 | 707.03 | 652.13 | 541.22 | Upgrade | |
Revenue Growth (YoY) | 50.57% | 42.85% | 19.37% | 8.42% | 20.49% | 26.25% | Upgrade |
Cost of Revenue | 566.51 | 469.27 | 350.23 | 339.25 | 357.44 | 316.31 | Upgrade |
Gross Profit | 907.03 | 736.38 | 493.78 | 367.79 | 294.69 | 224.91 | Upgrade |
Selling, General & Admin | 28.58 | 28.58 | 25.3 | 17.42 | 11.47 | 7.71 | Upgrade |
Other Operating Expenses | 599.58 | 472.33 | 307.82 | 212.65 | 175.36 | 135.28 | Upgrade |
Operating Expenses | 750.19 | 627.66 | 421 | 268.8 | 220.3 | 173.68 | Upgrade |
Operating Income | 156.84 | 108.72 | 72.78 | 98.99 | 74.39 | 51.23 | Upgrade |
Interest Expense | -47.63 | -40.37 | -22.79 | -8.67 | -2.31 | -4.71 | Upgrade |
Interest & Investment Income | 12.08 | 12.08 | 7.03 | 2.18 | 2.94 | 1.68 | Upgrade |
Other Non Operating Income (Expenses) | 30.02 | 26.32 | 5.4 | 16.38 | 2.15 | -0.47 | Upgrade |
EBT Excluding Unusual Items | 151.31 | 106.75 | 62.41 | 108.89 | 77.17 | 47.74 | Upgrade |
Gain (Loss) on Sale of Assets | 3.98 | 3.98 | - | - | - | - | Upgrade |
Other Unusual Items | 32.38 | 32.38 | - | - | - | - | Upgrade |
Pretax Income | 187.67 | 143.11 | 62.41 | 108.89 | 77.17 | 47.74 | Upgrade |
Income Tax Expense | 51.75 | 37.35 | 20.8 | 28.73 | 19.88 | 12.39 | Upgrade |
Net Income | 135.92 | 105.76 | 41.62 | 80.15 | 57.28 | 35.34 | Upgrade |
Preferred Dividends & Other Adjustments | -0 | -0 | - | - | - | - | Upgrade |
Net Income to Common | 135.92 | 105.76 | 41.62 | 80.15 | 57.28 | 35.34 | Upgrade |
Net Income Growth | 112.51% | 154.13% | -48.08% | 39.92% | 62.08% | 34.51% | Upgrade |
Shares Outstanding (Basic) | 20 | 20 | 18 | 11 | 7 | 7 | Upgrade |
Shares Outstanding (Diluted) | 20 | 20 | 18 | 11 | 7 | 7 | Upgrade |
Shares Change (YoY) | -10.50% | 9.02% | 70.59% | 41.13% | - | 0.00% | Upgrade |
EPS (Basic) | 6.94 | 5.37 | 2.31 | 7.58 | 7.64 | 4.71 | Upgrade |
EPS (Diluted) | 6.93 | 5.37 | 2.31 | 7.58 | 7.64 | 4.71 | Upgrade |
EPS Growth | 137.27% | 132.91% | -69.56% | -0.84% | 62.21% | 34.39% | Upgrade |
Free Cash Flow | -58.77 | -161.37 | -200 | -222.06 | -102.53 | 19.33 | Upgrade |
Free Cash Flow Per Share | -3.00 | -8.20 | -11.08 | -20.99 | -13.68 | 2.58 | Upgrade |
Gross Margin | 61.55% | 61.08% | 58.50% | 52.02% | 45.19% | 41.56% | Upgrade |
Operating Margin | 10.64% | 9.02% | 8.62% | 14.00% | 11.41% | 9.47% | Upgrade |
Profit Margin | 9.22% | 8.77% | 4.93% | 11.34% | 8.78% | 6.53% | Upgrade |
Free Cash Flow Margin | -3.99% | -13.38% | -23.70% | -31.41% | -15.72% | 3.57% | Upgrade |
EBITDA | 279.66 | 235.48 | 160.66 | 137.73 | 107.86 | 80.35 | Upgrade |
EBITDA Margin | 18.98% | 19.53% | 19.04% | 19.48% | 16.54% | 14.85% | Upgrade |
D&A For EBITDA | 122.82 | 126.76 | 87.88 | 38.74 | 33.47 | 29.12 | Upgrade |
EBIT | 156.84 | 108.72 | 72.78 | 98.99 | 74.39 | 51.23 | Upgrade |
EBIT Margin | 10.64% | 9.02% | 8.62% | 14.00% | 11.41% | 9.47% | Upgrade |
Effective Tax Rate | 27.58% | 26.10% | 33.32% | 26.39% | 25.77% | 25.96% | Upgrade |
Revenue as Reported | 1,552 | 1,281 | 860.71 | 730.33 | 661.95 | 543.99 | Upgrade |
Advertising Expenses | - | 8.15 | 5.98 | 17.31 | 11.12 | 6.3 | Upgrade |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.